ABSTRACT: An experiment was conducted to estimate relative bioavailability of Zn in 3 organic zinc sources with different chelation strength (Q f ) compared with ZnSO 4 . A total of 1,092, 1-d-old male broiler chicks were assigned randomly to 6 replicate cages (14 chicks per cage) for each of 13 treatments. Dietary treatments included the basal corn-soybean meal diet (27.82 mg of Zn/kg of DM) supplemented with 0, 30, 60, or 90 mg of added Zn as reagent ZnSO 4 , or Zn sources with Q f of 6.5 (11.93% Zn; Zn AA C), 30.7 (13.27% Zn; Zn Pro B), or 944.0 (18.61% Zn; Zn Pro A)/kg, which are considered as weak, moderate, or strong Q f , respectively. Bone Zn, pancreas Zn, pancreas metallothionein (MT) concentration, and pancreas MT messenger RNA (mRNA) were analyzed at 6, 10, or 14 d of age. The results showed that bone Zn, pancreas Zn, pancreas MT concentration, and pancreas MT mRNA increased linearly (P < 0.001) as dietary Zn concentration increased at all ages. At 6 d of age, pancreas MT mRNA differed (P < 0.001) among dietary Zn sources, and the same tendency was observed at 10 (P = 0.08) or 14 d (P = 0.06) of age. The R 2 for a linear model was greater on d 6 than d 10 or 14 for all the response criteria. Based on slope ratios from the multiple linear regression of pancreas MT mRNA concentration on daily intake of dietary Zn, the bioavailability of Zn AA C, Zn Pro B, and Zn Pro A relative to ZnSO 4 (100%) were 100.0, 121.1, and 72.3%, respectively, at 6 d of age. The results indicated that MT mRNA concentration in pancreas was more sensitive in reflecting differences in bioavailability among organic Zn sources than the MT concentration in pancreas or other indices. Moreover, the bioavailability of organic Zn sources was closely related to their Q f .
INTRODUCTION
Zinc is commonly supplemented to diets for livestock and poultry because many natural feed ingredients are marginally deficient in Zn. The feed industry has increased the use of organic trace mineral supplements during the last 10 yr. However, there are conflicting results reported regarding bioavailability of these products relative to traditional inorganic forms of the elements (Ammerman, 1995) . The chemical characteristics of organic Zn sources tested and the criterion used in bioavailability assays may explain the discrepancies in relative bioavailability estimates among research reports.
Chemical characteristics are considered important in predicting the bioavailability of chelated and complexed metals. Studies from our laboratory (Li et al., 2004; have shown that the bioavailability of Mn was closely related to chelation strengths (Q f ). To our knowledge, no experiment has evaluated the relationship between the chelating strength of organic Zn sources and their relative bioavailability values in broilers.
Different approaches have been used to search for the sensitive criteria in assessing the bioavailability of organic Zn sources. Bone Zn, pancreas metallothionein (MT), and pancreas MT messenger RNA (mRNA) could potentially be used as an index of Zn bioavailability in chicks (Sandoval et al., 1997; Cao et al., 2002; Huang et al., 2007) . The objective of this study was to estimate bioavailability of Zn in organic zinc sources with different Q f relative to ZnSO 4 when added to a practical corn-soybean meal diet for chicks at concentrations near the requirement.
MATERIALS AND METHODS
In this study, birds were handled in accordance with guidelines (Yang and Diao, 1999) approved by the Office of the Beijing Veterinarian.
Birds and Diets
The experiment was conducted using a total of 1,092 commercial 1-d-old Arbor Acres male broilers. The birds were randomly allotted by BW to 6 replicate cages (14 chicks per cage) for each of 13 treatment groups in a completely randomized design involving a 4 × 3 factorial arrangement of treatments (4 sources of Zn and 3 concentrations of added Zn plus a control with no added Zn). Chicks were housed in electrically heated, thermostatically controlled cages (100 × 50 × 45 cm) with fiberglass feeders and a 24-h constant-light schedule. The birds were allowed ad libitum access to the experimental diets and tap water that contained no detectable Zn. Birds were weighed, and feed intake was recorded at 6, 10, and 14 d of age.
The basal corn-soybean meal diet (Table 1) contained 27.82 mg of Zn/kg for the starter (d 1 to 14) diet. Diets were formulated so that all other nutrients except Zn met or exceeded requirements for broilers (NRC, 1994) . Based on the assumption that the Q f were highly correlated with bioavailability, 3 organic Zn sources with Q f of 6.55 [11.93% Zn; Zn AA C (Zinpro Corp., Eden Prairie, MN)], 30.7 [13.27% Zn; Zn Pro B (Fenyahua Bioengineering Co., Changzhi, P. R. China)], or 944.0 [18.61% Zn; Zn Pro A (Alltech Inc., Nicholasville, KY)]/kg were selected in this study. Three Zn sources were chosen with similar solubility in buffers at pH 2 or 5. The dietary treatments included the basal diet supplemented with 30, 60, or 90 mg of Zn/kg using reagent grade ZnSO 4 or 1 of the 3 organic Zn sources. All 3 organic Zn sources used in the present study and their Q f values and solubility data in buffers at pH 2 or 5 were all from the previous study by Liang (2006) . The Q f values of organic Zn sources were determined as described by Holwerda et al. (1995) using polarography with a hanging mercury drop electrode (Ag/AgCl reference electrode, Potentiostat/Galvanostat model 283; EG & G Inc., Gaithersburg, MD). All sources were obtained from independent distributors rather than directly from the product manufacturers.
A single batch of basal feed was mixed and divided into 13 aliquots according to the experimental treatment. Lysine or Met concentration in each treatment was balanced by supplementation of additional Lys or Met. Each Zn source was mixed with cornstarch to the same weight and mixed with each aliquot of the basal diet. Dietary Zn concentrations were presented in Table  2 . Because increased tissue MT mRNA concentration had been observed previously on the first day (Fernando et al., 1989) , which may affect the influence of supplemental Zn on tissue MT mRNA, birds were fed with the basal diet in the first 2 d, and experimental diets were provided beginning on d 3.
Sample Collections
At 6, 10, or 14 d of age, 4 birds from each cage were selected according to average BW within the cage after a 12-h fast, individually weighed, and killed by cervical dislocation. The pancreas was excised, and a subsample was frozen (−20°C) for Zn and MT content analysis, and another sample was frozen in liquid N for MT gene expression assays. The right tibia was excised and frozen in an individual heat-sealed polyethylene bag for Zn analysis. The samples from 4 individual chicks in each cage were pooled before analysis. 
Zinc Concentration
Zinc concentrations in Zn sources, diets, water, and tissues were determined by inductively coupled plasma emission spectroscopy (model IRIS Intrepid II, Thermal Jarrell Ash, Waltham, MA). Approximately 0.5 g of feed or pancreas sample was weighed in triplicate and digested with 10 mL of HNO 3 and 0.4 mL of HClO 4 at 200°C in a 50-mL calibrated flask until the solution became clear, and it was evaporated to almost dryness and diluted 1:20 (vol/vol) with 2% HNO 3 before analyses. Validation of the mineral analysis was conducted using bovine liver powder [GBW (E) 080193, National Institute of Standards and Technology, Beijing, China] as a standard reference material. Tibia bones were boiled for approximately 10 min in deionized water, and all soft tissue was removed. Then, bones were dried for 12 h at 105°C and ashed in a muffle furnace at 550°C for 16 h. Charred bones were digested as described above.
MT Concentration
Metallothionein concentration in pancreas was measured by 109 Cd 2+ hemoglobin affinity assay (Eaton and Toal, 1982) with a gamma spectrometer (model 4000, Beckman Instruments, Palo Alto, CA). The concentration of MT was calculated using a 109 Cd-MT binding stoichiometry of 7:1.
Pancreas RNA Extraction and MT mRNA Analysis
Total RNA in pancreas tissue was isolated using Trizol reagent (15596-026, Invitrogen Life Technologies, Carlsbad, CA). Concentrations of total RNA were estimated by measuring UV light absorbance at 260 nm (Ultrospec III, Perkin Elmer Cetus, Norwalk, CT). Reverse transcription was performed using the SuperScript III first-strand synthesis system for reverse transcription-PCR kit (12371-019, Invitrogen Life Technologies) and oligo(dT) 20 as a primer. According to the sequence of the gene published in GenBank, primers for MT and β-actin gene (housekeeping gene) were chosen (Primer Express Software, Applied Biosystems Inc., Foster, CA). Primer sequences, the position in the coding region, and the expected PCR product length are summarized in Table 3 .
Pancreas MT mRNA abundance was determined using real-time PCR quantitative analysis in the fluorescence detection system (7000HT, Applied Biosystems Inc.) according to optimized PCR protocols and the SYBR Green qPCR kit (4309155, Applied Biosystems Inc.), in which SYBR Green I was a double stranded DNA-specific fluorescent dye. The PCR reaction system (25 µL) contained 12.5 µL of SYBR Green qPCR mix, l µL of forward primer (10 µmol/L), l µL of reverse primer (10 µmol/L), 1 µL of cDNA template, and 4.5 µL of water. For the PCR reaction, an initial denaturation (10 min at 95°C) was repeated 10 times, and then, a 2-step amplification program (15 s at 95°C followed by 1 min at 60°C) was repeated 40 times. Realtime quantification was monitored by measuring the increase in fluorescence caused by the binding of SYBR Green dye to double-stranded DNA at the end of each amplification cycle. At the end of the PCR, dissociation was performed by slowly heating the samples from 60 to 95°C and continuous recording of the decrease in SYBR Green fluorescence that resulted from the dissociation of double-stranded DNA. The threshold cycle, defined as the cycle at which an increase in fluorescence above a defined baseline can be first detected, was determined for each sample.
The relative standard curve methods were used for quantification of gene expression. The MT and β-actin gene mRNA concentrations were determined from the threshold cycle plotted on the respective standard curves. The results were expressed as a ratio of MT mRNA to β-actin mRNA. Each PCR run included a 
Statistical Analysis
Data were analyzed by 2-way ANOVA using the GLM procedure (SAS Inst. Inc., Cary, NC). The model included the effects of Zn source, supplemental Zn amount, and their interaction. The cage was the experimental unit. Orthogonal polynomials were used to assess linear and quadratic responses to dietary Zn concentrations. Relative bioavailability values were determined using ZnSO 4 as the standard source by slope ratio comparisons from multiple linear regressions (Littell et al., 1995 . Because feed intake differences among treatments could affect Zn intake, regressions were calculated using dietary Zn intake (based on Zn assays of diets) as the independent variable rather than added Zn concentrations (Wedekind et al., 1992 (Wedekind et al., , 1994 Boling et al., 1998; Cao et al., 2002; Li et al., 2004) . Slope ratios and their SE were estimated using the method of error propagation as described by Littell et al. (1995) . Differences among sources were determined by differences in their respective regression coefficients. Differences among means were tested by the LSD method, and P < 0.10 was considered to be statistically significant (Li et al., 2004; Luo et al., 2007) .
RESULTS
The Zn source and concentration did not affect growth performance, and there were no interactions during the experimental period (Table 4) . Differences among Zn sources or interactions between Zn source and added Zn amount were not detected in bone Zn, pancreas Zn, or MT concentration in pancreas at 6, 10, or 14 d of age (Tables 5 and 6 ). As added Zn concentration increased, bone Zn, pancreas Zn, pancreas MT concentration, and its mRNA concentration increased linearly (P < 0.001) at 6, 10, or 14 d of age. On d 6, MT mRNA concentration of pancreas was affected (P < 0.001) by Zn source. Birds fed diets supplemented with Zn Pro A had the least MT mRNA concentration in the pancreas. The same tendency was observed on d 10 (P = 0.08) and 14 (P = 0.06).
The results of multiple linear regression analyses of tissue Zn concentration, pancreas MT concentration, and MT mRNA concentration, with daily added Zn intake by age, were listed in Table 7 . The R 2 value for each index on d 6 seemed to be greater than those on d 10 or 14, indicating that the response criteria on d 10 or 14 may be less well related to dietary Zn than d 6. Therefore, the response indices on d 6 were used to calculate relative bioavailability estimates.
Relative bioavailability values were calculated for bone Zn, pancreas Zn, MT concentration, and MT mRNA in pancreas by regression with supplemental Zn intake (Table 8) . When the response to ZnSO 4 was set at 100%, the estimated relative bioavailability for Zn AA C, Zn Pro B, and Zn Pro A were 104.5, 105.8, and 96.7%, respectively, for bone ash Zn concentration; 101.4, 103.8, 100.8%, respectively, for pancreas Zn concentrations; and 103.4, 111.4, 92.3%, respectively, for pancreas MT concentration. There were no differences in slopes among respective sources. When relative bioavailability was estimated based on pancreas MT mRNA, the values for Zn AA C, Zn Pro B, and Zn Pro A were 100.0, 121.1, and 72.3%, respectively. The slope for Zn Pro B with moderate chelation was greater (P < 0.05) than that for other Zn sources, and Zn Pro A with strong chelation was the least. There were no differences between ZnSO 4 and Zn AA C with weak chelation.
DISCUSSION
Bioavailability of trace minerals is defined as the proportion of the ingested element that is absorbed, trans- ported to its site of action, and converted to a physiologically active form. Thus, bioavailability implies not only absorption but also utilization of the mineral for a specific function. However, it is difficult to quantitatively evaluate the actual utilization of an element with a response criterion of sufficient sensitivity to determine statistical differences with a small population of animals (Li et al., 2005) . The earlier experiments designed to study the bioavailability of Zn usually used purified diets supplemented with low concentrations of Zn and growth performance and tibia Zn concentration as the response criteria (Edwards, 1959; Wedekind and Baker, 1990) . However, the estimate determined in a purified diet might not be applicable to conventional diets because of the absence of phytate and fiber (Wedekind et al., 1992) . Therefore, the later experiments were designed to use a corn-soybean meal diet with a short-term, high-supplemental Zn to determine relative bioavailability based on specific tissue Zn accumulation (Cao et al., 1996; Sandoval et al., 1997) . Decreased feed intake had been observed when dietary Zn concentrations were greater than approximately 200 mg/kg of Zn as reagent grade Zn sulfate (Henry et al., 1987; Sandoval et al., 1997 Sandoval et al., , 1998 . Some experiments attempted to use a practical corn-soybean meal diet and a supplemental Zn at near requirement to determine the bioavailability of the organic Zn sources (Sandoval et al., 1997; Cao et al., 2000) . The method offers several advantages in assessing Zn bioavailability such as minimizing the effect of decreased feed intake and also the applicability of the results to commercial conditions. Based on those findings, a practical cornsoybean diet (27.82 mg of Zn/kg) and 4 supplemental Zn concentrations (0, 30, 60, 90 mg/kg) were chosen in the current study. In this experimental design, finding a criterion that responds in a linear manner to dietary added Zn intake is most difficult and important.
Growth is one method to measure utilization but is generally a fairly unresponsive criterion for many mineral elements . Results of the growth performance from the current study were consistent with previous studies (Sandoval et al., 1997; Cao et al., 2000) , indicating that growth performance might be affected by factors other than Zn source and were not sensitive and specific indices for assessment of bioavailabilities of Zn sources for broilers. Bone Zn has been considered to be the most sensitive index for Zn bioavailability assay in chicks regardless of the low or high supplementation of Zn in the diet (Wedekind et al., 1992; Baker and Ammerman, 1995; Sandoval et al., 1997 Sandoval et al., , 1998 Sandoval et al., , 1999 Cao et al., 2000 Cao et al., , 2002 . However, in the present study, there was no difference in bone Zn Regression analyses of bone and pancreas Zn concentration, pancreas MT concentration, and pancreas MT mRNA concentration were based on cage average with 6 cages per Zn source; Zn AA C, Zinpro Corp., Eden Prairie, MN; Zn Pro B, Fenyahua Bioengineering Co., Changzhi, P. R. China; and Zn Pro A, Alltech Inc., Nicholasville, KY. It has been reported that pancreas is the most sensitive soft tissue to dietary Zn for chicks, and pancreas Zn concentration was shown to be a useful indicator for Zn requirement of broilers (Huang et al., 2007) . However, Zn concentration in the pancreas failed to reflect the differences among organic Zn sources in our study, implying that pancreas Zn concentration lacked the sufficient sensitivity required to detected differences among organic Zn sources. The result was supported by Wedekind et al. (1992) and Sandoval et al. (1997) who showed pancreas Zn concentration was not a useful criterion to evaluate bioavailability of Zn sources in chicks fed similar amounts of Zn.
Metallothionein is a small, cysteine-rich protein that can bind Zn and other heavy metals with high affinity, thus reducing its potentially harmful effects within the body. The MT is synthesized in tissues in response to dietary Zn (Cousins and Lee-Ambrose, 1992) . Tissue MT was positively related to dietary Zn intake in chicks (Sandoval, 1992; Huang et al., 2007) . The concentrations of MT in body fluids and tissues may be the best indicators to determine Zn availability from diets and mineral sources (Swinkels et al., 1994) . Cao et al. (2002) demonstrated that mucosal MT, as well as bone Zn, could potentially be used as an index of Zn bioavailability in chicks; however, their results were based on short-term Zn supplementation with dietary Zn concentrations near the requirement. Huang et al. (2007) also showed that the addition of 20 to 120 mg of Zn/ kg with ZnSO 4 ·7H 2 O to corn-soybean meal diet (28.32 mg of Zn/kg) increased pancreas MT linearly in broilers, which indicated that pancreas MT may be a useful indicator for Zn bioavailability in broilers. However, in the present experiment, there were no differences among Zn sources, indicating that MT concentration in pancreas lacked the sensitivity required to detect differences among Zn sources.
Methodological advances to assess gene expression have provided a new research tools to identify individual genes and groups of genes that produce normal and altered physiology. Quantitative real-time reverse transcription PCR provides a highly sensitive and reproducible method for measuring changes in expression of specific genes through transcript sequence detection. The emergence of this new molecular technique is especially promising for the development of a new generation of biomarkers. A notable example was provided by MT mRNA analyses in lymphocytes as a biomarker of Zn status for people. The MT mRNA concentrations were markedly reduced with mild experimental dietary Zn restriction (Allan et al., 2000) and increased rapidly with Zn supplementation (Sullivan et al., 1998) . Similar results also have been shown in chicks (Fleet et al., 1988; Huang et al., 2007 ). In the current study, MT mRNA concentrations in pancreas increased linearly as dietary Zn concentrations increased, which agrees with Huang et al. (2007) , indicating that dietary Zn affected pancreas MT gene transcription. The present experiment indicated that MT mRNA concentrations in the pancreas, as a functionally responsive criterion, could detect the differences among organic Zn sources as early as 6 d. Pancreas concentration of MT mRNA can be a more sensitive criterion than MT concentration in the pancreas or other indices for estimation of bioavailability of organic Zn sources. The difference between MT concentration and MT mRNA in distinguishing organic Zn sources could be explained by observations reported by Blalock et al. (1988) , who showed that maximal abundance of MT mRNA occurred a few hours before the increased amounts of protein were detected. The faster increase in mRNA compared with concentration, along with the observations in the current experiment, were consistent with the idea of MT mRNA being a fast and sensitive criterion for assessment of Zn bioavailability. Similar result was reported by Luo et al. (2007) , who showed that MnSOD (Mn superoxide dismutase) mRNA concentration could reflect differences among bioavailabilities of organic Mn sources as early as 7 d.
Any differences in chemical characteristics among Zn sources detected by various laboratory procedures are meaningless unless concurrent, measurable of improvements of bioavailability can also be detected. The Q f of an organic mineral source and its behavior under physiological conditions are perceived as key points in determining the value of products used as a supplement in animal nutrition (Li et al., 2004) . Li et al. (2004) demonstrated that for broilers, the organic Mn source with moderate chelation was more available than the organic Mn sources with weak or strong Q f . Our study with organic Zn sources with different Q f resulted in similar results. However, it should also be noted that Li et al. (2004) reported that the organic Mn source with strong Q f was the second most available among the 3 organic Mn sources, whereas in our study, the organic Zn source with strong Q f was the least available one. The reason for the disparity seems to be due to the difference in Q f . Holwerda et al. (1995) classified the organic trace mineral supplements with their Q f into 4 classes, in which the supplements with Q f -values less than 10 have weak Q f , between 10 and 100 have moderate Q f , between 100 and 1,000 have strong Q f , and greater than 1,000 have very strong Q f . In the study of Li et al. (2004) , the Q f -value of the organic Mn source with strong Q f was 115.4, close to moderate Q f ; however, in the present study, the Q f -value of the organic Zn source with strong Q f was 944.0, close to very strong Q f . Our present experiment demonstrated that the Zn-Pro A with near a very strong Q f was the least available, indicating that it might be difficult to be to dissociate Zn from Zn-Pro A and mobilize it for metabolic utilization by the body tissue. Additional research is needed to explore that possibility.
The regression of bioavailability on chemical characteristics was not calculated, but the results are consistent with an effect of Q f of these organic Zn sources on their relative bioavailability values for broilers. A Zn source with the moderate Q f was more available than the organic Zn sources with weak or strong Q f . Further research is required to verify the use of complex strength as an indicator of bioavailability with a wider range of organic Zn sources.
